<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38214079</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title><ISOAbbreviation>Euro Surveill</ISOAbbreviation></Journal><ArticleTitle>Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2300200</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2024.29.2.2300200</ELocationID><Abstract><AbstractText>BackgroundWomen are overrepresented among individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Biological (sex) as well as sociocultural (gender) differences between women and men might account for this imbalance, yet their impact on PASC is unknown.AimWe assessed the impact of sex and gender on PASC in a Swiss population.MethodOur multicentre prospective cohort study included 2,856 (46% women, mean age 44.2&#x2009;&#xb1;&#x2009;16.8 years) outpatients and hospitalised patients with PCR-confirmed SARS-CoV-2 infection.ResultsAmong those who remained outpatients during their first infection, women reported persisting symptoms more often than men (40.5% vs 25.5% of men; p&#x2009;&lt;&#x2009;0.001). This sex difference was absent in hospitalised patients. In a crude analysis, both female biological sex (RR&#x202f;=&#x202f;1.59; 95%&#x202f;CI: 1.41-1.79; p&#x2009;&lt;&#x2009;0.001) and a score summarising gendered sociocultural variables (RR&#x202f;=&#x202f;1.05; 95%&#x202f;CI: 1.03-1.07; p&#x2009;&lt;&#x2009;0.001) were significantly associated with PASC. Following multivariable adjustment, biological female sex (RR&#x202f;=&#x202f;0.96; 95%&#x202f;CI: 0.74-1.25; p&#x2009;=&#x2009;0.763) was outperformed by feminine gender-related factors such as a higher stress level (RR&#x202f;=&#x202f;1.04; 95%&#x202f;CI: 1.01-1.06; p&#x2009;=&#x2009;0.003), lower education (RR&#x202f;=&#x202f;1.16; 95%&#x202f;CI: 1.03-1.30; p&#x2009;=&#x2009;0.011), being female and living alone (RR&#x202f;=&#x202f;1.91; 95%&#x202f;CI: 1.29-2.83; p&#x2009;=&#x2009;0.001) or being male and earning the highest income in the household (RR&#x202f;=&#x202f;0.76; 95%&#x202f;CI: 0.60-0.97; p&#x2009;=&#x2009;0.030).ConclusionSpecific sociocultural parameters that differ in prevalence between women and men, or imply a unique risk for women, are predictors of PASC and may explain, at least in part, the higher incidence of PASC in women. Once patients are hospitalised during acute infection, sex differences in PASC are no longer evident.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gebhard</LastName><ForeName>Caroline E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xfc;tsch</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>These authors contributed equally.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebert</LastName><ForeName>Pimrapat</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Biometry and Clinical Epidemiology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gysi</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bengs</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todorov</LastName><ForeName>Atanas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deforth</LastName><ForeName>Manja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buehler</LastName><ForeName>Philipp K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meisel</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuepbach</LastName><ForeName>Reto A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinkernagel</LastName><ForeName>Annelies S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugger</LastName><ForeName>Silvio D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acevedo</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patriki</LastName><ForeName>Dimitri</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiggli</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beer</LastName><ForeName>J&#xfc;rg H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedl</LastName><ForeName>Andr&#xe9;e</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cantonal Hospital of Baden, Baden, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Twerenbold</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology and University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuster</LastName><ForeName>Gabriela M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pargger</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tschudin-Sutter</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schefold</LastName><ForeName>Joerg C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinetti</LastName><ForeName>Thibaud</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henze</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasqualini</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sager</LastName><ForeName>Dominik F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayrhofer</LastName><ForeName>Lilian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grieder</LastName><ForeName>Mirjam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tontsch</LastName><ForeName>Janna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franzeck</LastName><ForeName>Fabian C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Department of Informatics, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendel Garcia</LastName><ForeName>Pedro D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofmaenner</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheier</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartussek</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Intensive Care, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haider</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, and Department of Radiology, Harvard Medical School, Boston, Massachusetts, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xe4;mer</LastName><ForeName>Muriel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikail</LastName><ForeName>Nidaa</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Alexia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zellweger</LastName><ForeName>N&#xfa;ria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opi&#x107;</LastName><ForeName>Petra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portmann</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von K&#xe4;nel</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pazhenkottil</LastName><ForeName>Aju P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messerli</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buechel</LastName><ForeName>Ronny R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufmann</LastName><ForeName>Philipp A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treyer</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siegemund</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University Hospital Basel, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Held</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regitz-Zagrosek</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Gender in Medicine (GiM), Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebhard</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Euro Surveill</MedlineTA><NlmUniqueID>100887452</NlmUniqueID><ISSNLinking>1025-496X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013557" MajorTopicYN="N" Type="Geographic">Switzerland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gender</Keyword><Keyword MajorTopicYN="N">Post-COVID-19, Long-COVID, Long-Haulers</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Sex</Keyword><Keyword MajorTopicYN="N">Women</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> CG has received research grants and speaker&#x2019;s fees from the Novartis Foundation, from Sanofi Genzyme, Switzerland, and Bayer Pharmaceuticals outside of the submitted work. The University Hospital Zurich (CG, RRB, APP, MM, PAK) holds a research contract with GE Healthcare outside of the submitted work. AM has received research grants from Bayer Pharmaceuticals outside of the submitted work. JCS and TS reports (full departmental disclosure) grants from Orion Pharma, Abbott Nutrition International, B. Braun Medical AG, CSEM AG, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, Nestle, Pierre Fabre Pharma AG, Pfizer, Bard Medica S.A., Abbott AG, Anandic Medical Systems, Pan Gas AG Healthcare, Bracco, Hamilton Medical AG, Fresenius Kabi, Getinge Group Maquet AG, Dr&#xe4;ger AG, Teleflex Medical GmbH, Glaxo Smith Kline, Merck Sharp and Dohme AG, Eli Lilly and Company, Baxter, Astellas, Astra Zeneca, CSL Behring, Novartis, Covidien, Nycomed, and Phagenesis, outside of the submitted work. The money went into departmental funds, no personal financial gain applies. All authors declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38214079</ArticleId><ArticleId IdType="pmc">PMC10785203</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2024.29.2.2300200</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: NICE; 2022. Available from: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742
</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuters. Long COVID could become Finland's largest chronic disease. Reuters; 2022. Available from: https://www.reuters.com/article/us-health-coronavirus-finland-long-covid-idUSKBN2JH14W
</Citation></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259-64. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with post&#x2212;COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566-80. 10.1001/jamainternmed.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach K. New data shows long Covid is keeping as many as 4 million people out of work. Washington: Brookings Institution; 2022. Available from: https://www.brookings.edu/research/new-data-shows-long-covid-is-keeping-as-many-as-4-million-people-out-of-work
</Citation></Reference><Reference><Citation>Office for National Statistics. Half a million more people are out of the labour force because of long-term sickness. Newport: Office for National Statistics; 2022. Available from: https://www.ons.gov.uk/employmentandlabourmarket/peoplenotinwork/economicinactivity/articles/halfamillionmorepeopleareoutofthelabourforcebecauseoflongtermsickness/2022-11-10
</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133-46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2023;401(10393):e21-33. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Pawelek P. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 6 January 2022. Newport: Office for National Statistics; 2022. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/6january2022
</Citation></Reference><Reference><Citation>Kozak R, Armstrong SM, Salvant E, Ritzker C, Feld J, Biondi MJ, et al. Recognition of long-COVID-19 patients in a Canadian tertiary hospital setting: a retrospective analysis of their clinical and laboratory characteristics. Pathogens. 2021;10(10):1246. 10.3390/pathogens10101246</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10101246</ArticleId><ArticleId IdType="pmc">PMC8537802</ArticleId><ArticleId IdType="pubmed">34684195</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: The LONG-COVID-EXP-CM Multicenter Study. J Clin Med. 2022;11(2):413. 10.3390/jcm11020413</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>The Sex, Gender and COVID-19 Project. The COVID-19 sex-disaggregated data tracker. Cambridge: Global Health 50/50. [Accessed: 24 Aug 2023]. Available from: https://globalhealth5050.org/the-sex-gender-and-covid-19-project/the-data-tracker
</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374(1648):n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lott N, Gebhard CE, Bengs S, Haider A, Kuster GM, Regitz-Zagrosek V, et al. Sex hormones in SARS-CoV-2 susceptibility: key players or confounders? Nat Rev Endocrinol. 2023;19(4):217-31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9734735</ArticleId><ArticleId IdType="pubmed">36494595</ArticleId></ArticleIdList></Reference><Reference><Citation>Regner E. "Gender should be taken into account in clinical trials for anti-COVID-19 treatments&#x201d;. Press release. Brussels: European Parliament; 2021. Available from: https://www.europarl.europa.eu/news/en/press-room/20210706IPR07855/gender-should-be-taken-into-account-in-clinical-trials-for-anti-covid-treatments
</Citation></Reference><Reference><Citation>Tadiri CP, Gisinger T, Kautzy-Willer A, Kublickiene K, Herrero MT, Raparelli V, et al. The influence of sex and gender domains on COVID-19 cases and mortality. CMAJ. 2020;192(36):E1041-5. 10.1503/cmaj.200971</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.200971</ArticleId><ArticleId IdType="pmc">PMC7504881</ArticleId><ArticleId IdType="pubmed">32900766</ArticleId></ArticleIdList></Reference><Reference><Citation>Manandhar M, Hawkes S, Buse K, Nosrati E, Magar V. Gender, health and the 2030 agenda for sustainable development. Bull World Health Organ. 2018;96(9):644-53. 10.2471/BLT.18.211607</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.18.211607</ArticleId><ArticleId IdType="pmc">PMC6154065</ArticleId><ArticleId IdType="pubmed">30262946</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JL, Greaves L, Repta R. Better science with sex and gender: Facilitating the use of a sex and gender-based analysis in health research. Int J Equity Health. 2009;8(1):14. 10.1186/1475-9276-8-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-9276-8-14</ArticleId><ArticleId IdType="pmc">PMC2689237</ArticleId><ArticleId IdType="pubmed">19419579</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen MW, Stefanick ML, Peragine D, Neilands TB, Ioannidis JPA, Pilote L, et al. Gender-related variables for health research. Biol Sex Differ. 2021;12(1):23. 10.1186/s13293-021-00366-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-021-00366-3</ArticleId><ArticleId IdType="pmc">PMC7898259</ArticleId><ArticleId IdType="pubmed">33618769</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelletier R, Ditto B, Pilote L. A composite measure of gender and its association with risk factors in patients with premature acute coronary syndrome. Psychosom Med. 2015;77(5):517-26. 10.1097/PSY.0000000000000186</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000186</ArticleId><ArticleId IdType="pubmed">25984818</ArticleId></ArticleIdList></Reference><Reference><Citation>Bem SL. The measurement of psychological androgyny. J Consult Clin Psychol. 1974;42(2):155-62. 10.1037/h0036215</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/h0036215</ArticleId><ArticleId IdType="pubmed">4823550</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelletier R, Khan NA, Cox J, Daskalopoulou SS, Eisenberg MJ, Bacon SL, et al. Sex versus gender-related characteristics: Which predicts outcome after acute coronary syndrome in the young? J Am Coll Cardiol. 2016;67(2):127-35. 10.1016/j.jacc.2015.10.067</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.10.067</ArticleId><ArticleId IdType="pubmed">26791057</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;ring N. Zur Operationalisierung von Geschlecht im Fragebogen: Probleme und L&#xf6;sungsans&#xe4;tze aus Sicht von Mess-, Umfrage-, Gender-und Queer-Theorie. GENDER&#x2013;Zeitschrift f&#xfc;r Geschlecht. [On the operationalization of gender in questionnaires: Problems and suggested solutions from a perspective of measuring, survey, gender and queer theory. GENDER magazine for gender]. Kultur und Gesellschaft. 2013;5(2):94-113. German.</Citation></Reference><Reference><Citation>Cummings P. Methods for estimating adjusted risk ratios. Stata J. 2009;9(2):175-96. 10.1177/1536867X0900900201</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1536867X0900900201</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielsen AC, Lee KM, Boulicault M, Rushovich T, Gompers A, Tarrant A, et al. Sex disparities in COVID-19 outcomes in the United States: Quantifying and contextualizing variation. Soc Sci Med. 2022;294:114716. 10.1016/j.socscimed.2022.114716</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2022.114716</ArticleId><ArticleId IdType="pmc">PMC8743486</ArticleId><ArticleId IdType="pubmed">35042136</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID risk - a signal to address sex hormones and women&#x2019;s health. Lancet Reg Health Eur. 2021;11:100242. 10.1016/j.lanepe.2021.100242</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100242</ArticleId><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehingia N, Raj A. Sex differences in COVID-19 case fatality: do we know enough? Lancet Glob Health. 2021;9(1):e14-5. 10.1016/S2214-109X(20)30464-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30464-2</ArticleId><ArticleId IdType="pmc">PMC7834645</ArticleId><ArticleId IdType="pubmed">33160453</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam N, Khunti K, Dambha-Miller H, Kawachi I, Marmot M. COVID-19 mortality: a complex interplay of sex, gender and ethnicity. Eur J Public Health. 2020;30(5):847-8. 10.1093/eurpub/ckaa150</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckaa150</ArticleId><ArticleId IdType="pmc">PMC7545966</ArticleId><ArticleId IdType="pubmed">32745211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenham C, Smith J, Morgan R, Gender and COVID-19 Working Group . COVID-19: the gendered impacts of the outbreak. Lancet. 2020;395(10227):846-8. 10.1016/S0140-6736(20)30526-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30526-2</ArticleId><ArticleId IdType="pmc">PMC7124625</ArticleId><ArticleId IdType="pubmed">32151325</ArticleId></ArticleIdList></Reference><Reference><Citation>Horstmann S, Schmechel C, Palm K, Oertelt-Prigione S, Bolte G. The operationalisation of sex and gender in quantitative health-related research: a scoping review. Int J Environ Res Public Health. 2022;19(12):7493. 10.3390/ijerph19127493</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19127493</ArticleId><ArticleId IdType="pmc">PMC9224188</ArticleId><ArticleId IdType="pubmed">35742742</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations Development Programme (UNDP). Gender Inequality Index (GII). New York: UNDP. [Accessed: 14 Dec 2023]. Available from: https://hdr.undp.org/data-center/thematic-composite-indices/gender-inequality-index#/indicies/GII
</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>